Evaluation of spontaneous adverse event reports by primary reporter a 15-year review (1983 to 1997)

Drug Information Journal

Volumn 33, Issue 4, 1999, Pages 1117-1124

  Hornbuckle, Kenneth ^a   Wu, Hsiao Hui ^b   Fung, Man C ^a  

^a ELI LILLY AND COMPANY   (United States)

^b Intercontinental Region   (Taiwan)

Author keywords

Adverse drug reactions; Drug safety monitoring; Pharmacovigilance; Reporter type; Spontaneous adverse events reporting systems

Indexed keywords

ANAPHYLAXIS; ARTICLE; DATA BASE; DRUG DEPENDENCE; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG INFORMATION; DRUG MONITORING; DRUG OVERDOSE; DRUG SAFETY; FOOD AND DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032693076     PISSN: 00928615     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286159903300416     Document Type: Article

References (24)

1. Griffin JP, Weber JCP. Voluntary systems of adverse reaction reporting. Part I, Adverse Drug Reactions. Acute Poisoning Rev. 1985;4:213-230.
2. Griffin JP, Weber JCP. Voluntary systems of adverse reaction reporting. Part II, Adverse Drug Reactions. Acute Poisoning Rev. 1986;5:23-55.
3. Griffin JP, Weber JCP. Voluntary systems of adverse reaction reporting. Part III, Adverse Drug Reactions. Acute Poisoning Rev. 1989;8:203-215.
4. Griffin JP. Survey of the spontaneous adverse drug reaction reporting schemes in fifteen countries. Br J Clin Pharma. 1986;22:83S-100S.
5. Rossi AC, Knapp DE. Discovery of new adverse drug reactions: a review of the Food and Drug Administration's spontaneous reporting system. JAMA. 1983;249:2226-2228.
6. Rossi AC, Knapp DE. Discovery of new adverse drug reactions: a review of the Food and Drug Administration's spontaneous reporting system. JAMA. 1984;252:1030-1033.
7. Rawlins MD. Spontaneous reporting of adverse drug reactions I: the data. Br J Clin Pharma. 1988;26:1-5.
8. Rawlins MD. Spontaneous reporting of adverse drug reactions I: uses. Br J Clin Pharma. 1988;26:7-11.
9. Rossi AC, Knapp DE, Anello C, et al. Discovery of adverse drug reactions: a comparison of selected phase IV studies with spontaneous reporting methods. JAMA. 1983;249:2226-2228.
10. Piazza-Hepp TD, Kennedy DL. Reporting of adverse events to MedWatch. Am J Health-Syst Pharm. 1995;52:1436-1439.
11. Fletcher AP. Spontaneous adverse drug reaction reporting vs event monitoring: a comparison. J Royal Soc Med. 1991;84:341-344.
12. Haramburu F, Begaud B, Moride Y. Temporal trends in spontaneous reporting of unlabelled adverse drug reactions. Br J Clin Pharma. 1997;44:299-301.
13. Tubert P, Begaud B, Pere JC, Haramburu F, Lellouch J. Power and weakness of spontaneous reporting: a probabilistic approach. J Clin Epidemiol. 1992;45: 283-286.
14. Sachs RM, Bortnichak EA. An evaluation of spontaneous adverse drug reaction monitoring systems. Am J Med. 1986;81(Suppl 5B):59-65.
15. Fincham JE. Adverse drug reaction reporting and pharmacists. J Clin Pharm Ther. 1989;14:79-81.
16. Winstanley PA, Irvin LE, Smith JC, Orme L, Breckenridge AM. Adverse drug reactions: a hospital pharmacy-based reporting scheme. Br J Clin Pharmacol. 1989;28:113-116.
17. Tyler LS, Nickman NA. Hospital pharmacy compliance with JCAHO standards and ASHP guidelines for reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:845-850.
18. Lee KK, Chan TY, Raymond K, Critchley JA. Pharmacists' attitudes toward adverse drug reaction reporting in Hong Kong. Ann Pharmacother. 1994; 28:1400-1403.
19. Generali JA, Danish MA, Rosenbaum SE. Knowledge of and attitudes about adverse drug reaction reporting among Rhode Island pharmacists. Ann Pharmacother. 1995;29:365-369.
20. Roger AS, Israel E, Smith CR, et al. Physician knowledge, attitudes, and behavior related to adverse drug events. Arch Intern Med. 1988;148:1596-1600.
21. Bateman DN, Sanders GL, Rawlins MD. Attitudes to adverse drug reaction reporting in the Northern Region. Br J Clin Pharmacol. 1992;34:421-426.
22. Cosentino M, Leoni O, Banfi F, Lecchini S, Frigo G. Attitudes to adverse drug reaction reporting by medical practitioners in a Northern Italian district. Pharmacolog Res. 1997;35:85-88.
23. Belton KJ. Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group. European J Clin Pharmacol. 1997; 52:423-427.
24. Hall M, McCormack P, Arthurs N, Feely J. The spontaneous reporting of adverse drug reactions by nurses. Br J Clin Pharmacol. 1995;40:173-175.